HOME >> MEDICINE >> NEWS
New data show CAS in clinical practice has comparable MAE rate with pivotal sapphire trial

Cordis Endovascular, a division of Cordis Corporation, announced today that preliminary results of its CASES peri-approval study (CASES-PMS) showed that high surgical-risk patients treated with carotid artery stenting (CAS) had identical 30-day major adverse event (MAE) rates with that of patients treated with CAS in the pivotal SAPPHIRE study. The data, which were presented today at the American College of Cardiology Scientific Sessions, showed an MAE rate of 4.8 percent (62/1279) among patients treated with CAS in CASES-PMS compared with 4.8 percent (8/167) of CAS-treated patients in the randomized arm of the SAPPHIRE trial.

CASES-PMS is a multi-center, prospective, single arm open-label peri-approval study designed to assess the outcomes of stenting with Cordis' PRECISE* Nitinol Self-Expanding Stent, and ANGIOGUARD XP* Emboli Capture Guidewire System in the treatment of obstructive artery disease in relation to the outcomes of the pivotal SAPPHIRE study. The study's primary objective is to demonstrate that outcomes in a peri-approval setting, including use of a detailed training program in CAS for physicians not experienced in CAS, allow outcomes that are similar to those obtained in the pivotal trial setting.

"These initial findings are very important because they both corroborate the findings of the landmark SAPPHIRE study, and demonstrate that formalized training in carotid stenting allows physicians from multiple specialties with prior endovascular experience to perform carotid stenting and obtain outcomes as good as the experts that performed the clinical trials," said Dennis Donohoe, M.D., Vice President, Worldwide Regulatory and Clinical Affairs, Cordis Corporation. "The outcomes in this study are an important additional set of data supporting the generalizability of results from the SAPPHIRE trial, the only randomized clinical trial of carotid stenting compared to carotid endarterectomy."

Cordis Endovascular initiated CASES,
'"/>

Contact: Steven Cooper
steven.cooper@edelman.com
917-301-7566
Edelman Public Relations
13-Mar-2006


Page: 1 2

Related medicine news :

1. New contracts support clinical trials on antibiotic-resistant, community-acquired staph infections
2. Damon Runyon renews its $2.25 million investment to support young clinical cancer investigators
3. International journal group updates guidelines on registration of clinical trials
4. Urgent need for guidance on mobile phone use in clinical care
5. New prostate cancer clinical guidelines to be released
6. First clinical trial of gene therapy for childhood blindness
7. Acute coronary syndrome therapy improvements linked with fewer deaths and improved clinical outcomes
8. Taking the wraps off drug safety data from clinical trials
9. Preclinical results of Geovaxs AIDS vaccines demonstrate potential to protect against disease
10. 30+ AIDS vaccine clinical trials in 24 countries, research occurring on every continent
11. NIH-funded program co-directed by Mailman School of PH faculty to expedite clinical research process

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/15/2018)... ... ... Today David Hyde Apparel debuts the first, fully effective sweat-proof and stain-resistant ... for confidence and comfort year-round, the new shirt leverages a patent-pending, double-sided fabric to ... humid of climates. , The brainchild of two recent University of Central Florida graduates ...
(Date:8/14/2018)... ... August 14, 2018 , ... Gastro Health, LLC ... roles for healthcare executives Simon Frisch and Chris Weinstein, who have been appointed ... their roles at a time of tremendous growth for the group, which has ...
(Date:8/11/2018)... ... ... Dr. Siavash Eftekhari, Oral and Maxillofacial Surgeon at Monarch Dental® in Grapevine, ... deliver dental care in impoverished communities. Along with a team of fellow Smile ... help deliver care to over 550 individuals in need. , This outreach was hosted ...
(Date:8/9/2018)... ... August 09, 2018 , ... ... implants have ruptured, according to cross-referenced data from The American Society of Plastic ... implant rupture rates monitored by the FDA. As an MRI is recommended by ...
(Date:8/9/2018)... ... August 09, 2018 , ... Thanks ... and the company’s independent distributors, customers, and employees, the newly established Isagenix ... exceeding the $2 million goal. 100 percent of the donations will fund grants ...
Breaking Medicine News(10 mins):
(Date:8/2/2018)... ... August 02, 2018 , ... UMD Professor Utpal Pal leads a team ... years from the National Institute of Allergy and Infectious Diseases (NIAID), part of the ... immune responses of ticks that contribute to the spread of major diseases like Lyme ...
(Date:8/2/2018)... ... 2018 , ... As kids begin heading back to school, ... include concerns with speaking, listening, reading, writing, and social interactions. Children may be ... parents should know, according to the American Speech-Language-Hearing Association (ASHA): , How Speech-Language ...
(Date:8/2/2018)... ... August 02, 2018 , ... Although there is a ... it is contradictory and based on a generalized “best practices” approach. But now doctors ... the right combination for optimal health. , Technology exists to help people find the ...
Breaking Medicine Technology:
Cached News: